학술논문
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
Document Type
Article
Author
Arisaka, T; Asakura, T; Azuma, N; Fukuda, S; Fukushima, Y; Harada, N; Inoue, S; Ishida, H; Ishii, H; Ishikawa, S; Jinnouchi, H; Kaneko, S; Kanno, K; Kato, M; Kato, Y; Kawada, T; Kim, H; Kiyosue, A; Matsuoka, O; Miho, O; Nakamoto, S; Nakamura, S; Nakanishi, S; Nishimura, H; Numata, A; Ohama, T; Okabe, T; Okuguchi, F; Osonoi, T; Sasaki, T; Seino, H; Shin, K; Shiraiwa, T; Sugiura, T; Wada, S; Yamauchi, A; Yabe, Daisuke ; Nakamura, Jiro; Kaneto, Hideaki; Deenadayalan, Srikanth; Navarria, Andrea; Gislum, Mette; Inagaki, Nobuya
Source
In The Lancet Diabetes & Endocrinology May 2020 8(5):392-406
Subject
Language
ISSN
2213-8587